Extracorporeal Membrane Oxygenation in the NICU

Area of Science:

• Neonatal medicine
• Pediatric critical care
• Cardiopulmonary support

Background:

• Extracorporeal membrane oxygenation (ECMO) initially developed for adults, is now a vital rescue therapy for neonates.
• It addresses life-threatening conditions like congenital diaphragmatic hernia, meconium aspiration syndrome, persistent pulmonary hypertension, and sepsis in infants.
• ECMO has demonstrated significant improvements in survival rates for these critical neonatal conditions.

Purpose of the Study:

• To provide a comprehensive overview of neonatal extracorporeal membrane oxygenation (ECMO).
• To cover the history, development, and essential aspects of neonatal ECMO therapy.
• To inform clinicians on patient selection, management, and potential complications.

Main Methods:

• Review of historical development and clinical application of neonatal ECMO.
• Analysis of patient selection criteria for ECMO initiation in neonates.
• Description of clinical management protocols, ECMO circuit technology, and weaning strategies.
• Identification and discussion of potential complications associated with neonatal ECMO.

Main Results:

• ECMO has evolved into a crucial life-saving intervention for critically ill neonates.
• Established criteria guide patient selection, optimizing outcomes for respiratory and cardiac failure.
• Effective management protocols and circuit technology contribute to increased survival rates.
• Understanding potential complications is key for successful ECMO implementation.

Conclusions:

• Neonatal ECMO is a proven, life-saving therapy for infants with severe respiratory and cardiac conditions.
• This overview synthesizes key information on neonatal ECMO, from its history to management and complications.
• Optimized patient selection and clinical management are crucial for maximizing ECMO's survival benefit in neonates.